JW (Cayman) Therapeutics Co. Ltd

JWCTF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$267-$350-$240-$388
Dep. & Amort.$0$43$47$50
Deferred Tax$0$0$0$0
Stock-Based Comp.$5$19$19$3
Change in WC$0-$16$0$3
Other Non-Cash$263$159-$13$171
Operating Cash Flow$0-$145-$188-$160
Investing Activities
PP&E Inv.$0-$2-$3-$6
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$0-$10-$2
Investing Cash Flow$0-$2-$13-$8
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$33$57-$89
Financing Cash Flow$0$33$57-$89
Forex Effect$0$3$7-$10
Net Chg. in Cash$0$0$0$0
Supplemental Information
Beg. Cash$0$0$0$1,273
End Cash$0$0$0$1,273
Free Cash Flow$0-$148-$191-$166
JW (Cayman) Therapeutics Co. Ltd (JWCTF) Financial Statements & Key Stats | AlphaPilot